文献速递免疫规划妇幼与学校卫生

季节性三价灭活流感疫苗在孕妇中的安全性与免疫原性

Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women.
PubMed 文献 · Vaccine · 2018-11-08

该前瞻性随机临床研究纳入100名18-39岁、妊娠≥14周的孕妇,接种2008-2009季Fluzone®或Fluarix®三价灭活流感疫苗,评估7天内局部和全身反应、严重不良事件及妊娠结局,并检测接种前和接种后28天血凝抑制抗体。多数反应轻微且自限,无发热≥100°F报告,无疫苗相关严重不良事件;两种疫苗免疫应答相似,对甲型流感株血凝抑制应答强,对乙型流感株相对较低。结论为季节性灭活流感疫苗在孕妇中耐受良好且具有免疫原性。

要点

  • 孕妇接种季节性三价灭活流感疫苗后多数局部和全身反应轻微且自限。
  • 研究中未报告发热≥100°F,也未发现疫苗相关严重不良事件。
  • 两种疫苗对甲型流感株血凝抑制应答强,对乙型流感株相对较低。

核心结论

  • 季节性灭活流感疫苗在孕妇中耐受良好且具有免疫原性。

研究设计与样本

  • 前瞻性随机临床研究纳入100名18-39岁、妊娠≥14周的孕妇,单次肌内接种2008-2009季Fluzone®或Fluarix®三价灭活流感疫苗。

主要发现

  • 多数注射部位和全身反应轻微且自限,未报告发热≥100°F,无疫苗相关严重不良事件。
  • 两种疫苗免疫应答相似,对甲型流感株血凝抑制应答强,对乙型流感株相对较低。

临床怎么用

  • 可为妊娠≥14周孕妇接种季节性三价灭活流感疫苗提供安全性和免疫原性依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the United States, seasonal inactivated influenza vaccine (IIV) is recommended for pregnant women; however, in early 2009, immunization rates were low, partly due to limited prospective data and concerns about vaccine safety. OBJECTIVE: We conducted a randomized study of two licensed seasonal trivalent IIVs (IIV3) to assess their safety and immunogenicity in pregnant women. STUDY DESIGN: In this prospective, randomized clinical study, 100 pregnant women, 18-39 years of age and ≥14 weeks gestation received a single intramuscular dose of 2008-2009 Fluzone® or Fluarix®. Injection site and systemic reactions were recorded for 7 days after vaccination and serious adverse events (SAEs) and pregnancy outcomes were documented. Serum samples collected before and 28 days after vaccination were tested for hemagglutination inhibition (HAI) antibody levels. RESULTS: The majority of the injection site and systemic reactions were mild and self-limited after both vaccines. No fever ≥100 °F was reported. There were no vaccine-associated SAEs. Immune responses to influenza vaccine antigens were similar for the two study vaccines, with robust HAI responses against influenza A strains, and relatively lower responses for influenza B strains. CONCLUSION: Seasonal inactivated influenza vaccines were well tolerated and immunogenic in pregnant women. SYNOPSIS: In this prospective clinical trial, we demonstrated that immunization with seasonal trivalent, inactivated influenza vaccine in the second and third trimester of pregnancy is immunogenic and safe.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Munoz FM, Jackson LA, Swamy GK, et al. Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women. Vaccine. 2018. PMID: 30416018. doi:10.1016/j.vaccine.2018.10.088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。